argenx NV ADR (ARGX) — the peer cohort
As of 2026-11-09 — scores re-bake nightly. Cohort = shared Closelooknet index membership first, then sector. Diary readings, not advice.
argenx NV ADR ranks 5 of 7 in its cohort on the Closelooknet composite (64/100) — the cohort is led by Halozyme Therapeutics Inc at 71/100.
| Name | Composite | Momentum | Quality | Valuation | Signal | Off 52w high |
|---|---|---|---|---|---|---|
| ARGX argenx NV ADR | 64 | 78 | 74 | 28 | ok | 10.3% |
| HALO Halozyme Therapeutics Inc | 71 | 75 | 94 | 38 | info | 23.2% |
| ARGX.BR Argen-X | 65 | 82 | 75 | 29 | ok | 7.7% |
| ONC BeOne Medicines AG | 65 | 91 | 64 | 30 | ok | 0.6% |
| REGN Regeneron Pharmaceuticals Inc | 65 | 83 | 73 | 46 | watch | 8.8% |
| BION.SW BB Biotech AG | 60 | 73 | 95 | 73 | ok | 6.1% |
| RIGL Rigel Pharmaceuticals Inc | 60 | 76 | 89 | 74 | info | 20.1% |
Scores are relative readings across the Closelooknet coverage universe — methodology in the company-scoring explainer. Signal lights come from the nightly signal board.
FAQ · from the current data · as of 2026-11-09
Quick answers
Who are argenx NV ADR's peers in the Closelooknet universe?
The cohort is drawn from shared Closelooknet index membership first, then sector: Halozyme Therapeutics Inc (HALO), Argen-X (ARGX.BR), BeOne Medicines AG (ONC), Regeneron Pharmaceuticals Inc (REGN), BB Biotech AG (BION.SW), Rigel Pharmaceuticals Inc (RIGL), as of 2026-11-09.
How does ARGX score against its peers?
argenx NV ADR's composite reads 64/100, ranking 5 of 7 in its cohort as of 2026-11-09; the cohort's highest composite is Halozyme Therapeutics Inc at 71/100. Closelooknet scores are research diary readings, not ratings or advice.
Mentioned on Closelooknet
Where ARGX appears in the diary — 1 piece, newest first. Every link is our own writing.
Go deeper
Dailies
- A chart pick published at 95.10 this morning trades 107.92 by midday — Robinhood's triangle breaks up through the 100 shelf — as the CAC snaps seven straight red sessions and Bitcoin adds another six percent above 77,000
Barchart's large-cap 52-week new-high list, as of 11:59 CDT, carries 31 names and reads like the ex-tech thesis printed as breadth: twelve are health care, biotech or pharma — ARGX, BDX, BIO, CORT, HALO, MRK, REGN, RVTY, THC, TVTX, TXG…
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeOne Medicines AGindustry
- REGN Regeneron Pharmaceuticals Incindustry
- BION.SW BB Biotech AGindustry
- RIGL Rigel Pharmaceuticals Incindustry
- KOD Kodiak Sciences Incindustry
- REPL Replimune Group Incindustry
- XNCR Xencor Incindustry
- VCEL Vericel Corp Ordindustry
- MRNA Moderna Incindustry
- VRDN Viridian Therapeutics Incindustry
- UCB.BR UCB SAindustry
- TUB.BR Tubize-Finindustry
- SEPN Septerna, Inc. Common Stockindustry
- MAZE Maze Therapeutics, Inc. Common Stockindustry
- ADMA ADMA Biologics Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- VIR Vir Biotechnology Incindustry
- LEGN Legend Biotech Corpindustry